Sana biotechnology presents data at isscr 2022 annual meeting showing survival of transplanted hypoimmune ipsc-derived differentiated cell types without immunosuppression in non-human primates

First demonstration of the survival of allogeneic islet cells, cardiomyocytes, and retinal pigment epithelium cells transplanted into an immunocompetent non-human primate model without any immune suppression
SANA Ratings Summary
SANA Quant Ranking